loadpatents
Patent applications and USPTO patent grants for KASID; USHA.The latest application filed is for "anti-apoptotic gene scc-s2 and diagnostic and therapeutic uses thereof".
Patent | Date |
---|---|
Anti-apoptotic Gene Scc-s2 And Diagnostic And Therapeutic Uses Thereof App 20110104252 - KASID; USHA ;   et al. | 2011-05-05 |
Anti-apoptotic Gene Scc-s2 And Diagnostic And Therapeutic Uses Thereof App 20100041142 - Kasid; Usha ;   et al. | 2010-02-18 |
Gene BRCC-3 and diagnostic and therapeutic uses thereof Grant 7,442,520 - Kasid , et al. October 28, 2 | 2008-10-28 |
Gene SCC-112 and diagnostic and therapeutic uses thereof Grant 7,351,811 - Kasid , et al. April 1, 2 | 2008-04-01 |
Chemosensitizing with liposomes containing oligonucleotides Grant 7,262,173 - Kasid , et al. August 28, 2 | 2007-08-28 |
Gene BRCC-2 and diagnostic and therapeutic uses thereof Grant 7,253,272 - Kasid , et al. August 7, 2 | 2007-08-07 |
Gene shinc-3 and diagnostic and therapeutic uses thereof Grant 7,244,565 - Kasid , et al. July 17, 2 | 2007-07-17 |
Gene BRCC-1 and diagnostic and therapeutic uses thereof App 20070104718 - Gokhale; Prafulla ;   et al. | 2007-05-10 |
Anti-apoptopic gene SCC-S2 and diagnostic and therapeutic uses thereof App 20070087992 - Kasid; Usha ;   et al. | 2007-04-19 |
Compositions and methods for inducing cell death Grant 7,074,807 - Kasid , et al. July 11, 2 | 2006-07-11 |
Liposomes containing oligonucleotides App 20060141020 - Kasid; Usha ;   et al. | 2006-06-29 |
Gene SCC-112 and diagnostic and therapeutic uses thereof App 20040248218 - Kasid, Usha ;   et al. | 2004-12-09 |
Gene SHINC-1 and diagnostic and therapeutic uses thereof App 20040161775 - Kasid, Usha ;   et al. | 2004-08-19 |
Gene BRCC-2 and diagnostic and therapeutic uses thereof App 20040115714 - Kasid, Usha ;   et al. | 2004-06-17 |
Gene BRCC-3 and diagnostic and therapeutic uses thereof App 20040106571 - Kasid, Usha ;   et al. | 2004-06-03 |
Anti-apoptopic gene SCC-S2 and diagnostic and therapeutic uses thereof App 20040082771 - Kasid, Usha ;   et al. | 2004-04-29 |
Compositions and methods for inducing cell death App 20040024025 - Kasid, Usha ;   et al. | 2004-02-05 |
Gene shinc-3 and diagnostic and therapeutic uses thereof App 20040005603 - Kasid, Usha ;   et al. | 2004-01-08 |
Gene BRCC-1 and diagnostic and therapeutic uses thereof App 20030228317 - Gokhale, Prafulla ;   et al. | 2003-12-11 |
Cationic liposomal delivery system and therapeutic use thereof App 20030229040 - Kasid, Usha ;   et al. | 2003-12-11 |
Gene SHINC-2 and diagnostic and therapeutic uses thereof App 20030225023 - Kasid, Usha ;   et al. | 2003-12-04 |
Chemosensitizing with liposomes containing oligonucleotides App 20030215489 - Kasid, Usha ;   et al. | 2003-11-20 |
Cationic liposomal delivery system and therapeutic use thereof Grant 6,559,129 - Kasid , et al. May 6, 2 | 2003-05-06 |
Liposomes containing oligonucleotides App 20020160038 - Kasid, Usha ;   et al. | 2002-10-31 |
Liposomes containing oligonucleotides Grant 6,333,314 - Kasid , et al. December 25, 2 | 2001-12-25 |
Liposomes containing oligonucleotides Grant 6,126,965 - Kasid , et al. October 3, 2 | 2000-10-03 |
NCAGE Code | 477G5 | KASID USHA |
CAGE Code | 477G5 | KASID, USHA |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.